To test OX40 blockade in this human MASLD model, liver slices were incubated in GFIPO media in the presence of Rocatinlimab, an antagonistic OX40 monoclonal antibody (α-OX40) currently studied in clinical trials for atopic dermatitis15. This evidence concerns the gene TNFRSF4 and metabolic dysfunction-associated steatotic liver disease.